Palisade Bio (PALI) vs Sutro Biopharma (STRO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Sutro Biopharma (STRO) has outperformed Palisade Bio (PALI) over the past year, gaining 74.5% versus a loss of 11.9%. Over five years, STRO leads with a -92.3% price change compared with -99.9% for PALI. Palisade Bio is the larger company by market cap ($257.9 million vs $243.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PALI | STRO |
|---|---|---|
| Share price | $1.48 | $14.66 |
| Market cap | $257.92M | $243.08M |
| 1-day change | -0.67% | +1.45% |
| YTD return | -37.02% | +26.71% |
| 1-year return | -11.90% | +74.52% |
| 5-year return | -99.93% | -92.28% |
| P/E ratio (TTM) | 2.47 | — |
| EPS (TTM) | $0.60 | $-17.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.86 | $43.85 |
| 52-week low | $1.32 | $7.15 |
| Distance from 52-week high | -48.25% | -66.57% |
| Average volume | 2.64M | 289.73K |
| Shares outstanding | 174.27M | 16.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STRO has outperformed PALI by 86.4 percentage points over the past year.
PALI vs STRO FAQ
Which is bigger, Palisade Bio or Sutro Biopharma?
Palisade Bio (PALI) is larger, with a market capitalization of $257.92M compared with $243.08M for Sutro Biopharma (STRO).
Which stock has performed better over the past year, PALI or STRO?
STRO returned +74.52% over the past 12 months, compared with -11.90% for PALI (price return, excluding dividends). Past performance does not predict future results.
Are Palisade Bio and Sutro Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.